IE000B9PQW54
IE000B9PQW54
VanEck Genomics and Healthcare Innovators UCITS ETF
Loading chart...
Holdings & Portfolio Structure
Holdings as of 10/05/2026Detailed breakdown of ETF components
All Holdings
# | Ticker | Name | Sector | Industry | Market Cap | Weight | P/E | Fwd P/E | D/E | P/B | P/S | EV/EBITDA | P/FCF | FCF Yield | Revenue Estimate | EPS Estimate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Moderna, Inc. | Healthcare | Biotechnology | 80,17 Mrd. € | 9.18% | - | -50.70 | 19.04% | 13.28 | 40.32 | -34.08 | 300.18 | 0.33% | FY Cur +8.09% (21) Q Cur -12.17% (14) FY Next +16.07% (19) Q Next -24.31% (13) | FY Cur -15.53% (21) Q Cur -149.18% (15) FY Next +43.00% (20) Q Next -37.19% (14) | |
| 2 | Vertex Pharmaceuticals Incorpor | Healthcare | Biotechnology | 115,31 Mrd. € | 7.25% | 29.71 | 25.23 | 9.77% | 6.38 | 10.26 | 23.86 | 49.17 | 2.03% | FY Cur +10.45% (16) Q Cur +11.16% (13) FY Next +9.84% (16) Q Next +3.20% (14) | FY Cur -11.12% (16) Q Cur -115.38% (13) FY Next +23.62% (16) Q Next +721.48% (14) | |
| 3 | Natera, Inc. | Healthcare | Diagnostics & Research | 51,55 Mrd. € | 6.98% | - | -2028.91 | 13.09% | 31.59 | 21.34 | -247.20 | 555.23 | 0.18% | FY Cur +26.17% (22) Q Cur +19.45% (20) FY Next +20.65% (22) Q Next +5.85% (18) | FY Cur +5.05% (16) Q Cur +58.50% (15) FY Next +86.32% (16) Q Next +60.98% (14) | |
| 4 | Regeneron Pharmaceuticals, Inc. | Healthcare | Biotechnology | 68,6 Mrd. € | 6.82% | 18.46 | 12.11 | 8.54% | 2.36 | 4.95 | 14.58 | 25.07 | 3.99% | FY Cur +20.31% (25) Q Cur +20.96% (19) FY Next +7.56% (23) Q Next +8.04% (18) | FY Cur +27.56% (27) Q Cur +35.49% (22) FY Next -10.42% (9) Q Next +11.61% (21) | |
| 5 | Veeva Systems Inc. | Healthcare | Health Information Services | 42,79 Mrd. € | 6.37% | 46.71 | 28.89 | 2.04% | 6.61 | 13.86 | 36.29 | 38.12 | 2.62% | FY Cur +15.49% (28) Q Cur +15.25% (24) FY Next +12.27% (27) Q Next +0.96% (24) | FY Cur +14.02% (27) Q Cur +14.86% (26) FY Next +10.99% (26) Q Next -1.52% (26) | |
| 6 | Illumina, Inc. | Healthcare | Diagnostics & Research | 37,49 Mrd. € | 6.23% | 51.90 | 45.46 | 89.04% | 14.80 | 9.35 | 35.77 | 52.66 | 1.90% | FY Cur +6.48% (19) Q Cur +6.34% (17) FY Next +6.46% (19) Q Next +5.84% (16) | FY Cur +10.69% (21) Q Cur +1.31% (19) FY Next +14.20% (21) Q Next +13.15% (18) | |
| 7 | DexCom, Inc. | Healthcare | Medical Devices | 28,33 Mrd. € | 5.24% | 33.38 | 26.90 | 53.35% | 12.11 | 6.39 | 22.31 | 31.08 | 3.22% | FY Cur +12.19% (27) Q Cur +9.89% (25) FY Next +10.89% (27) Q Next +5.43% (24) | FY Cur +27.47% (26) Q Cur +10.35% (23) FY Next +17.37% (26) Q Next +9.28% (22) | |
| 8 | Guardant Health, Inc. | Healthcare | Diagnostics & Research | 20,06 Mrd. € | 4.60% | - | -405.82 | - | - | 19.00 | -53.09 | 844.66 | 0.12% | FY Cur +38.24% (25) Q Cur +32.20% (21) FY Next +35.29% (25) Q Next +5.32% (20) | FY Cur +19.43% (21) Q Cur +19.79% (17) FY Next +71.86% (19) Q Next +11.31% (17) | |
| 9 | BioNTech SE | Healthcare | Biotechnology | 21,74 Mrd. € | 3.71% | - | -19.82 | 1.78% | 1.22 | 9.19 | -7.23 | - | -1.02% | FY Cur -37.73% (18) Q Cur -29.90% (11) FY Next +0.51% (17) Q Next -52.56% (11) | FY Cur -896.28% (10) Q Cur +730.57% (5) FY Next -2.30% (10) Q Next -199.60% (5) | |
| 10 | Alnylam Pharmaceuticals, Inc. | Healthcare | Biotechnology | 27,79 Mrd. € | 3.59% | 37.83 | 18.73 | 220.62% | 22.98 | 6.48 | 28.19 | 114.66 | 0.87% | FY Cur +47.50% (26) Q Cur +14.73% (20) FY Next +26.78% (26) Q Next +9.32% (20) | FY Cur +73.90% (14) Q Cur -21.24% (14) FY Next +40.62% (14) Q Next +19.29% (14) | |
| 11 | GENSCRIPT BIO | Healthcare | Biotechnology | 10,99 Mrd. € | 2.34% | - | 588.89 | 8.82% | 3.04 | 114.43 | 459.62 | 1019.39 | 0.10% | FY Cur -7.31% (6) Q Cur - (0) FY Next +20.79% (7) Q Next - (0) | FY Cur -71.46% (1) Q Cur - FY Next +140.00% (2) Q Next - | |
| 12 | Insulet Corporation | Healthcare | Medical Devices | 8,37 Mrd. € | 2.28% | 25.33 | 17.50 | 66.69% | 6.60 | 3.07 | 15.84 | 39.60 | 2.52% | FY Cur +21.38% (25) Q Cur +17.94% (23) FY Next +13.68% (25) Q Next +7.29% (22) | FY Cur +30.94% (24) Q Cur +28.06% (23) FY Next +18.80% (24) Q Next +16.31% (22) | |
| 13 | Qiagen N.V. | Healthcare | Diagnostics & Research | 8,36 Mrd. € | 2.25% | 23.04 | 17.37 | 49.25% | 2.79 | 4.46 | 13.70 | 25.13 | 3.98% | FY Cur +2.16% (17) Q Cur +0.38% (9) FY Next +5.06% (17) Q Next +7.17% (9) | FY Cur +2.28% (13) Q Cur -3.35% (9) FY Next +7.32% (13) Q Next +5.41% (9) | |
| 14 | Arrowhead Pharmaceuticals, Inc. | Healthcare | Biotechnology | 7,89 Mrd. € | 2.23% | - | -12.73 | 295.98% | 19.03 | 13.20 | -41.68 | - | -0.55% | FY Cur -44.33% (15) Q Cur -77.18% (14) FY Next -27.60% (15) Q Next -21.82% (6) | FY Cur -35300.40% (14) Q Cur -752.98% (14) FY Next -39.29% (14) Q Next +11.01% (7) | |
| 15 | 10x Genomics, Inc. | Healthcare | Medical Devices | 9,38 Mrd. € | 2.14% | - | 1051.91 | 9.54% | 12.73 | 17.03 | -232.90 | 58.49 | 1.71% | FY Cur -3.47% (17) Q Cur -0.79% (16) FY Next +9.72% (17) Q Next +16.00% (16) | FY Cur -70.21% (3) Q Cur +12.28% (2) FY Next +109.08% (3) Q Next +75.00% (2) | |
| 16 | PROMEDICUS FPO [PME] | Healthcare | Health Information Services | 10,8 Mrd. € | 1.74% | 62.54 | 72.61 | 0.49% | 38.40 | 66.16 | 83.05 | 175.12 | 0.57% | FY Cur +29.41% (14) Q Cur - (0) FY Next +23.98% (14) Q Next - (0) | FY Cur +32.45% (12) Q Cur - FY Next +25.03% (12) Q Next - | |
| 17 | Hinge Health, Inc. | Healthcare | Health Information Services | 7,41 Mrd. € | 1.73% | 33.96 | 33.66 | 1.71% | 23.97 | 11.53 | 78.63 | 27.71 | 3.61% | FY Cur +46.36% (16) Q Cur +45.71% (14) FY Next +26.35% (15) Q Next +6.58% (14) | FY Cur -8.43% (14) Q Cur +35.84% (13) FY Next +27.44% (13) Q Next +10.65% (13) | |
| 18 | GRAIL, Inc. | Healthcare | Diagnostics & Research | 5,6 Mrd. € | 1.71% | - | -17.04 | 3.59% | 2.47 | 38.00 | -13.61 | - | -1.65% | FY Cur +22.88% (11) Q Cur +22.25% (10) FY Next +25.35% (11) Q Next +15.61% (10) | FY Cur +35.72% (5) Q Cur +22.80% (4) FY Next -9.78% (4) Q Next -9.99% (5) | |
| 19 | Hims & Hers Health, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 6,44 Mrd. € | 1.67% | - | 41.94 | 477.13% | 22.26 | 2.80 | -712.58 | 8.49 | 11.77% | FY Cur +36.65% (14) Q Cur +49.05% (13) FY Next +24.59% (14) Q Next +6.92% (13) | FY Cur -209.86% (11) Q Cur -6.13% (11) FY Next +174.80% (11) Q Next +103.59% (11) | |
| 20 | Twist Bioscience Corporation | Healthcare | Biotechnology | 9,45 Mrd. € | 1.52% | - | -399.45 | 24.36% | 22.47 | 24.53 | -82.20 | - | -0.61% | FY Cur +21.18% (12) Q Cur +24.77% (11) FY Next +20.16% (11) Q Next +2.34% (8) | FY Cur +54.63% (4) Q Cur +67.26% (3) FY Next +58.32% (4) Q Next +6.33% (3) | |
| 21 | JD HEALTH | Healthcare | Pharmaceutical Retailers | 13,09 Mrd. € | 1.47% | 16.63 | 14.35 | 1.42% | 1.59 | 1.46 | 12.56 | 21.27 | 4.70% | FY Cur +16.99% (16) Q Cur - (0) FY Next +15.37% (18) Q Next - (0) | FY Cur +4.09% (11) Q Cur - FY Next +18.14% (11) Q Next - | |
| 22 | Krystal Biotech, Inc. | Healthcare | Biotechnology | 8,76 Mrd. € | 1.42% | 41.56 | 35.78 | 0.65% | 7.22 | 22.28 | 44.41 | 64.68 | 1.55% | FY Cur +29.71% (9) Q Cur +31.99% (9) FY Next +28.43% (10) Q Next +7.22% (9) | FY Cur +13.10% (11) Q Cur -25.59% (10) FY Next +19.79% (11) Q Next +6.75% (10) | |
| 23 | CRISPR Therapeutics AG | Healthcare | Biotechnology | 4,61 Mrd. € | 1.32% | - | -15.18 | 44.87% | 2.95 | 385.49 | -6.42 | - | -4.18% | FY Cur +204.90% (17) Q Cur +1760.02% (15) FY Next +283.48% (16) Q Next -1.10% (15) | FY Cur +31.18% (18) Q Cur +10.01% (17) FY Next +21.03% (18) Q Next -10.08% (17) | |
| 24 | M3 INC | Healthcare | Health Information Services | 6,97 Mrd. € | 1.26% | 26.96 | - | 8.47% | 3.05 | 3.48 | 13.24 | - | - | FY Cur +9.27% (12) Q Cur +10.32% (6) FY Next +9.21% (12) Q Next +11.75% (6) | FY Cur +6.23% (12) Q Cur +18.71% (4) FY Next +12.09% (12) Q Next +23.06% (4) | |
| 25 | Ionis Pharmaceuticals, Inc. | Healthcare | Biotechnology | 6,72 Mrd. € | 1.25% | - | -40.71 | 497.80% | 17.05 | 8.61 | -12.57 | - | -4.61% | FY Cur -2.59% (23) Q Cur +18.68% (18) FY Next +48.21% (23) Q Next +28.75% (18) | FY Cur -75.03% (10) Q Cur -49.59% (8) FY Next +58.84% (10) Q Next +3.14% (8) |
Results: 49
Weight 9.18%
Market Cap €80.17B
P/E -
Fwd P/E -50.7
Weight 7.25%
Market Cap €115.31B
P/E 29.7
Fwd P/E 25.2
Weight 6.98%
Market Cap €51.55B
P/E -
Fwd P/E -2028.9
Weight 6.82%
Market Cap €68.6B
P/E 18.5
Fwd P/E 12.1
Weight 6.37%
Market Cap €42.79B
P/E 46.7
Fwd P/E 28.9
Weight 6.23%
Market Cap €37.49B
P/E 51.9
Fwd P/E 45.5
Weight 5.24%
Market Cap €28.33B
P/E 33.4
Fwd P/E 26.9
Weight 4.6%
Market Cap €20.06B
P/E -
Fwd P/E -405.8
Weight 3.59%
Market Cap €27.79B
P/E 37.8
Fwd P/E 18.7
Weight 2.34%
Market Cap €10.99B
P/E -
Fwd P/E 588.9
Weight 2.28%
Market Cap €8.37B
P/E 25.3
Fwd P/E 17.5
Weight 2.25%
Market Cap €8.36B
P/E 23.0
Fwd P/E 17.4
Weight 2.23%
Market Cap €7.89B
P/E -
Fwd P/E -12.7
Weight 2.14%
Market Cap €9.38B
P/E -
Fwd P/E 1051.9
Weight 1.74%
Market Cap €10.8B
P/E 62.5
Fwd P/E 72.6
Weight 1.73%
Market Cap €7.41B
P/E 34.0
Fwd P/E 33.7
Weight 1.67%
Market Cap €6.44B
P/E -
Fwd P/E 41.9
Weight 1.52%
Market Cap €9.45B
P/E -
Fwd P/E -399.4
Weight 1.47%
Market Cap €13.09B
P/E 16.6
Fwd P/E 14.4
Weight 1.42%
Market Cap €8.76B
P/E 41.6
Fwd P/E 35.8
Weight 1.32%
Market Cap €4.61B
P/E -
Fwd P/E -15.2
Weight 1.25%
Market Cap €6.72B
P/E -
Fwd P/E -40.7
Results 1 - 25 of 49
Per page:
Page 1 / 2